chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Discomfort, Fatigue, Headache, Nausea
Clinical narrative: Headache; low fever; nausea; fatigue; loss of appetite; general discomfort; sore arm; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the arm right on 27Apr2021 at 10:30(at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included food allergy like allergy to walnuts, apples and many stone fruits. Concomitant medications included cetirizine hydrochloride (ZYRTEC) and naproxen sodium (ALEVE) since an unknown date for an unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the arm right on 06Apr2021 at 14:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 28Apr2021 at 02:00, the patient experienced headache, low fever, nausea, fatigue, loss of appetite, general discomfort and sore arm. It began approximately 14 hours after injection and easing 28 hours after injection and completely gone within 40 hours but still had sore arm. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event headache, low fever, nausea, fatigue, loss of appetite and general discomfort were recovered on an unknown date in Apr2021. The clinical outcome of the event sore arm was not recovered at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Headache; low fever; nausea; fatigue; loss of appetite; general discomfort; sore arm; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the arm right on 27Apr2021 at 10:30(at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included food allergy like allergy to walnuts, apples and many stone fruits. Concomitant medications included cetirizine hydrochloride (ZYRTEC) and naproxen sodium (ALEVE) since an unknown date for an unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the arm right on 06Apr2021 at 14:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 28Apr2021 at 02:00, the patient experienced headache, low fever, nausea, fatigue, loss of appetite, general discomfort and sore arm. It began approximately 14 hours after injection and easing 28 hours after injection and completely gone within 40 hours but still had sore arm. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event headache, low fever, nausea, fatigue, loss of appetite and general discomfort were recovered on an unknown date in Apr2021. The clinical outcome of the event sore arm was not recovered at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph nodes in neck, head, collar bone, shoulder and chest; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 18Apr2021 at 10:00(at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergies from an unknown date. Concomitant medication included rosuvastatin (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 20Apr2021 at 17:00, the patient experienced swollen lymph nodes in neck, head, collar bone, shoulder and chest. Swollen lymph nodes in collar bone and shoulder persisted 11 days later. The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event swollen lymph nodes in neck, head, collar bone, shoulder and chest were not resolved at the time of this report.  No follow-up attempts are needed; information about lot number cannot be obtained.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Headache, Hypersomnia, Nausea, Pain
Clinical narrative: High fever; Severe headache; Bad vision.; Body aches.; No energy; Nausea; slept 20 hours; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: Er8763) via an unspecified route of administration in the left arm on 24Apr2021 at 12:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received penicillin for an unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Ew0150), via an unspecified route of administration in the left arm on 01Apr2021 at 13:00 (at the age of 55-years old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 25Apr2021 at 00:00, the patient had experienced high fever, severe headache, bad vision, body aches, nausea. She had slept for 20 hours and did not have energy.  Five days later she was still sick. The clinical outcome of the events high fever, severe headache, bad vision, general body pains, no energy, nausea and slept 20 hours was resolving at the time of report.   No follow-up attempts are needed. No further information is expected
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Visual impairment
Clinical narrative: High fever; Severe headache; Bad vision.; Body aches.; No energy; Nausea; slept 20 hours; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: Er8763) via an unspecified route of administration in the left arm on 24Apr2021 at 12:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received penicillin for an unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Ew0150), via an unspecified route of administration in the left arm on 01Apr2021 at 13:00 (at the age of 55-years old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 25Apr2021 at 00:00, the patient had experienced high fever, severe headache, bad vision, body aches, nausea. She had slept for 20 hours and did not have energy.  Five days later she was still sick. The clinical outcome of the events high fever, severe headache, bad vision, general body pains, no energy, nausea and slept 20 hours was resolving at the time of report.   No follow-up attempts are needed. No further information is expected
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Lethargy, Lymph node pain, Lymphadenopathy, Pain in extremity
Clinical narrative: swollen lymph node (left side); swollen lymph node (left side), tender to touch, painful at this point; leg hurting; lymph node (left side), tender to touch,; very lethargic, unable to keep energy; extremely tired; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 14Apr2021 at 10:30 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included spironolactone (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. The patient previously took penicillin for an unknown indication on an unknown date and experienced allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 24Mar2021 at 12:00 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021, the patient underwent nasal swab test and the result was negative. On 14Apr2021, the  patient experienced lethargic and tiredness. On 19Apr2021, the patient experienced swollen lymph nodes,  lymph node tenderness, lymph node pain and leg pain. Its reported that the patient was feeling unwell since she received the shot, very lethargic, unable to keep energy up during the day, extremely tired, recently a swollen lymph node (left side), tender to touch, painful at this point, as well as leg hurting for a full day. Pain medication doesn't work well either. Therapeutic measures taken for the reported events included treatment with pain medications. The clinical outcome of the events of lethargic, tiredness, swollen lymph nodes, lymph node tenderness, and lymph node pain was not recovered at the time of this report. The clinical outcome of the event of lymph node pain was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: swollen lymph node (left side); swollen lymph node (left side), tender to touch, painful at this point; leg hurting; lymph node (left side), tender to touch,; very lethargic, unable to keep energy; extremely tired; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 14Apr2021 at 10:30 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included spironolactone (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. The patient previously took penicillin for an unknown indication on an unknown date and experienced allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 24Mar2021 at 12:00 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021, the patient underwent nasal swab test and the result was negative. On 14Apr2021, the  patient experienced lethargic and tiredness. On 19Apr2021, the patient experienced swollen lymph nodes,  lymph node tenderness, lymph node pain and leg pain. Its reported that the patient was feeling unwell since she received the shot, very lethargic, unable to keep energy up during the day, extremely tired, recently a swollen lymph node (left side), tender to touch, painful at this point, as well as leg hurting for a full day. Pain medication doesn't work well either. Therapeutic measures taken for the reported events included treatment with pain medications. The clinical outcome of the events of lethargic, tiredness, swollen lymph nodes, lymph node tenderness, and lymph node pain was not recovered at the time of this report. The clinical outcome of the event of lymph node pain was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pruritus
Clinical narrative: swollen lymph node on left jaw; itchy skin; This is a spontaneous report from a contactable other healthcare professional, the patient. A 43-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8737) via an unspecified route of administration in the arm left on 02Apr2021 at 16:00 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included finasteride (MANUFACTURER UNKNOWN) and minoxidil (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6199) via an unspecified route of administration in the arm left on 12Mar2021 at 16:00 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021 at 16:00 the patient experienced swollen lymph node on left jaw and itchy skin. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events swollen lymph node on left jaw and itchy skin was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: 1 x 1.5 inch rash right under the injection site; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the arm right on 25Apr2021 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication included norgestimate, ethinyl estradiol (Ortho tri-cyclen). Relevant past drug history was provided as not that the patient knows of. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021 the patient experienced 1 x 1.5-inch rash right under the injection site (vaccination site rash). The clinical outcome of the event vaccination site rash was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation delayed, SARS-CoV-2 test
Clinical narrative: delayed menstrual cycle; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EP8736) via an unspecified route of administration in the left arm on 23Apr2021 (at the age of 25- years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Concomitant medications included escitalopram oxalate (LEXAPRO) for unknown indication form unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0150) via an unspecified route of administration in the left arm on 02Apr2021.Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021, the patient underwent rapid COVID-19 virus test and the result was found to be negative. On 23Apr2021 the patient experienced delayed menstrual cycle. The clinical outcome of the event delayed menstrual cycle was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: I started having CCU - Cold Contact Urticaria on 4/26 or at least thats when I was exposed to cold and noticed hives; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the arm left on 13Apr2021 at 00:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was reported as none. Concomitant medication included liprosine (MANUFACTURER UNKNOWN). The patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm left on 23Mar2021 at 00:00 (at the age of 62-years-old) for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Apr2021 at 00:00, the patient experienced CCU - Cold Contact Urticaria on 4/26 or at least that's when he was exposed to cold and noticed hives. The event resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether the patient had received any treatment for the event. The clinical outcome of the event urticaria was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Hot flush, Insomnia
Clinical narrative: Hives on face and neck; Hot ears; tingling/vibrating skin on face after any exercise daily (still occurring 7 days after shot); severe headaches; chills; fatigue; hot flashes; sleeplessness; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 22Apr2021 at  09:45 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient's had allergies to penicillin, pollen and tree nuts. The patient's concomitant medications included cetirizine hydrochloride(ZYRTEC, birth control medication (unspecified) and multivitamin. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 01Apr2021 at 12:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Apr2021 at 12:00, the patient experienced hives on face and neck, hot ears (red ears), tingling/vibrating skin on face after any exercise daily, severe headaches, chills, hot flashes, fatigue and sleeplessness. Therapeutic measures taken were not reported. The clinical outcome of the events hives, red ear syndrome, tingling skin, headaches, chills, hot flashes, fatigue and sleeplessness were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Red ear syndrome, Urticaria
Clinical narrative: Hives on face and neck; Hot ears; tingling/vibrating skin on face after any exercise daily (still occurring 7 days after shot); severe headaches; chills; fatigue; hot flashes; sleeplessness; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 22Apr2021 at  09:45 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient's had allergies to penicillin, pollen and tree nuts. The patient's concomitant medications included cetirizine hydrochloride(ZYRTEC, birth control medication (unspecified) and multivitamin. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 01Apr2021 at 12:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Apr2021 at 12:00, the patient experienced hives on face and neck, hot ears (red ears), tingling/vibrating skin on face after any exercise daily, severe headaches, chills, hot flashes, fatigue and sleeplessness. Therapeutic measures taken were not reported. The clinical outcome of the events hives, red ear syndrome, tingling skin, headaches, chills, hot flashes, fatigue and sleeplessness were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Vision blurred, Visual impairment
Clinical narrative: vision issues and seeing spots or wavy lines.; vision issues blurred; intense intermittent headaches; intense waves of nausea; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the arm left on 20Apr2021 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included mast cell activation syndrome, postural orthostatic tachycardia syndrome, hemiplegic migraine, hypertension, ehlers-danlos syndrome, and methylenetetrahydrofolate reductase deficiency. The patient received several unspecified medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the right arm on 18Mar2021 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 20Apr2021 at 17:45, the patient experienced intense intermittent headaches, intense waves of nausea, vision issues blurred, and seeing spots or wavy lines. The patient was 9 days post 2nd dose at the time of reporting and was still experiencing the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event intense intermittent headaches, intense waves of nausea, vision issues blurred, and seeing spots or wavy lines were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Illness
Clinical narrative: Got really sick for a day about 2 weeks; Fever; Chills; Joint pains in hands, knees, hips, back and heels; Headache; Extreme fatigue; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 08Apr2021 at 11:00 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included attention deficit hyperactivity disorder and inflammatory arthritis. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Concomitant medications included methylphenidate (MANUFACTURER UNKNOWN), multivitamins (MANUFACTURER UNKNOWN) and hydroxychloroquine (MANUFACTURER UNKNOWN) all for unknown indications from an unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021 at 21:00 the patient got really sick (for a day), fever, chills, joint pains in hands, knees, hips, back and heels, headache, extreme fatigue and nausea. The events resulted in doctor or other healthcare professional office/clinic visit. On 25Apr2021, the patient underwent Sars-cov-2 RNA, QL, RT PCR (nasal swab) and the result was negative. The clinical outcome of the events got really sick  was resolved on 24Apr2021; while that of  fever, chills, joint pains in hands, knees, hips, back and heels, headache, extreme fatigue and nausea was resolved on an unknown date in Apr2021. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, SARS-CoV-2 test
Clinical narrative: Got really sick for a day about 2 weeks; Fever; Chills; Joint pains in hands, knees, hips, back and heels; Headache; Extreme fatigue; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 08Apr2021 at 11:00 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included attention deficit hyperactivity disorder and inflammatory arthritis. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Concomitant medications included methylphenidate (MANUFACTURER UNKNOWN), multivitamins (MANUFACTURER UNKNOWN) and hydroxychloroquine (MANUFACTURER UNKNOWN) all for unknown indications from an unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021 at 21:00 the patient got really sick (for a day), fever, chills, joint pains in hands, knees, hips, back and heels, headache, extreme fatigue and nausea. The events resulted in doctor or other healthcare professional office/clinic visit. On 25Apr2021, the patient underwent Sars-cov-2 RNA, QL, RT PCR (nasal swab) and the result was negative. The clinical outcome of the events got really sick  was resolved on 24Apr2021; while that of  fever, chills, joint pains in hands, knees, hips, back and heels, headache, extreme fatigue and nausea was resolved on an unknown date in Apr2021. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Rash
Clinical narrative: Pain; Rash; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 22Apr2021 at 14:15 (at the age of 56-years-old) as a single dose for COVID-19 immunization. Medical history included diabetes and heart disease, unspecified. The patient had allergies to walnuts and pecans. The patient previously took bactrim, trulicity and invokana and was allergic. Concomitant medications included metformin (MANUFACTURER UNKNOWN), apixaban (ELIQUIS), furosemide (LASIX), carvedilol (CARVIDOL) and insulin human injection, isophane (INSULIN N) from unknown dates for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 14:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021 at 06:00, the patient experienced pain and rash. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures taken was not reported. The clinical outcome of the events pain and rash was not recovered at the time of this report.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: Sore left arm; Leg muscle pain; Fatigue; Low grade fever; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 27Apr2021 at 10:00 (at the age of 41-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications included norethisterone acetate; ethinylestradiol (JUNEL FE 24), levothyroxine 112 micrograms (MANUFACTURER UNKNOWN) and metformin hydrochloride (METFORMIN ER 500) all for an unknown indication from an unknown date. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 06Apr2021 at 10:00 (at the age of 41-year-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 27Apr2021 at 20:00, the patient experienced sore left arm for 48 hours, leg muscle pain for 08 hours, fatigue for 24 hours and low-grade fever for 30 hours. The clinical outcome of the events muscle pain was resolved on 28Apr2021 at 04:00;  fatigue was resolved on 28Apr2021 at 20:00; low grade fever was resolved on 29Apr2021 at 02:00 and sore left arm was resolved on 29Apr2021 at 20:00.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Breast pain, Fatigue, Pain, Pyrexia
Clinical narrative: Swelling in the armpit and breast on the same side as the injection; Pain in the breast on the same side as the injection; Pain in the armpit on the same side as the injection; Body aches; Low grade fever; Fatigue; Light, red and non raised rash at the injection site; Non raised rash at the injection site; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 27Apr2021 at 13:45 (at the age of 22-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma and food allergy. Concomitant medications were not reported. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 06Apr2021 at 14:00 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Apr2021 at 15:30, the patient experienced pain and swelling in the armpit and breast on the same side as the injection, body aches, low grade fever, fatigue, light red non raised rash at the injection site. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events which included treatment with BENADRYL. The clinical outcome of the event swelling in the armpit and breast on the same side as the injection, pain in the armpit and breast on the same side as the injection, body aches, low grade fever, fatigue and light red non raised rash at the injection site were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling, Vaccination site erythema, Vaccination site rash
Clinical narrative: Swelling in the armpit and breast on the same side as the injection; Pain in the breast on the same side as the injection; Pain in the armpit on the same side as the injection; Body aches; Low grade fever; Fatigue; Light, red and non raised rash at the injection site; Non raised rash at the injection site; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 27Apr2021 at 13:45 (at the age of 22-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma and food allergy. Concomitant medications were not reported. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 06Apr2021 at 14:00 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Apr2021 at 15:30, the patient experienced pain and swelling in the armpit and breast on the same side as the injection, body aches, low grade fever, fatigue, light red non raised rash at the injection site. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events which included treatment with BENADRYL. The clinical outcome of the event swelling in the armpit and breast on the same side as the injection, pain in the armpit and breast on the same side as the injection, body aches, low grade fever, fatigue and light red non raised rash at the injection site were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Cold sweat, Dehydration, Headache, Pain, Pain in extremity
Clinical narrative: Cold sweats; Body aches; Dehydrated; Sore arm; Headache; This is a spontaneous report from a contactable pharmacist. A 26-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 26-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications were not reported. Previously, the patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route on an unspecified date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date, the patient woke up in middle of the night after receiving vaccine the previous day (as reported) with cold sweats, body aches, headache all morning, sore arm and dehydrated. The adverse events were starting to subside then. The clinical outcome of the event cold sweats, body aches, headache, sore arm and dehydrated was recovering at the time of this report.   No follow-up attempts are needed; information about lot number cannot be obtained.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular
Clinical narrative: Back to back periods; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161), via an unspecified route of administration in the left arm on 14Apr2021 at 15:30(at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension (HTN), Crohn's disease and ulcerative colitis. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included vedolizumab (ENTYVIO), mesalazine (MESALAMINE), amlodipine (AMLODIPINE) and olmesartan (OLMESARTAN) all taken from unknown dates for unknown indications. The patient previously received REMICADE for an unknown indication. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination.  The patient reported that on 16Apr2021, two days after the vaccination she had her period which lasted for four days and it was a normal cycle, then again on 23Apr2021, the patient experienced another period which lasted for four days and it was a normal cycle (irregular periods). The patient reported that the back-to-back periods were completely out of normal. The clinical outcome of the event back-to-back periods (irregular periods) was resolved on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Neck pain, Pain in extremity, Vaccination site pain
Clinical narrative: Left arm from injection site became very sore.; lower neck became very sore.; shoulder blade became very sore.; fore arm area became very sore.; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158), via an unspecified route of administration in the left arm on 11Apr2021 at 17:00 (at the age of 55-year-old), as a single dose for COVID-19 immunisation. Medical history included hypertension and asthma. Concomitant medications included metoprolol succinate (METOPROLOL), atorvastatin (MANUFACTURER UNKNOWN), lamotrigine (MANUFACTURER UNKNOWN) and fluticasone furoate; umeclidinium bromide; vilanterol trifenatate (TRELEGY) for an unknown indication from an unknown date. The patient did not have a history of past drug therapy. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 19Apr2021, the patient had experienced very sore left arm from injection site to lower neck to shoulder blade and down my arm to my fore arm area which started about 7 days after injection and was still feeling the same till the day of report. Therapeutic measures were taken as the result of adverse events, which included treatment with heating pad. The clinical outcome of the events very sore left arm from injection site to lower neck to shoulder blade and down my arm to my fore arm area  was not resolved at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Peripheral swelling, Pruritus, Pyrexia
Clinical narrative: right arm swollen; itchy; fever; bruised; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm right on 02Apr2021 at 10:00  (at the age of 42-year-old) and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the arm right on an unknown date, both as a single dose for COVID-19 immunisation. Medical history included stroke, blood pressure high and high cholesterol. Concomitant medications included too many unspecified drugs (as reported). The patient previously took Peroxide and adhesive. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021 the patient experienced two spots covering the top right arm swollen, itchy, fever and bruised. They looked like a bullseye as reported. The clinical outcome of the events arm swollen, itchy, fever and bruised were not recovered at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Pain, Pyrexia, Restlessness
Clinical narrative: Tired; Slept most of the day; Strong muscle aches; Body aches; Restless all night; Low grade fever; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 11Apr2021 at 11:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension. Concomitant medications included lisinopril 10mg (MANUFACTURER UNKNOWN), allium sativum extract (KYOLIC GARLIC), ascorbic acid, tocopheryl acetate, ubidecarenone, zinc oxide, cupric oxide, betacarotene, selenium, manganese sulfate (COQ10), cyanocobalamin (VITAMIN B12) and colecalciferol (VITAMIN D3), all taken for unknown indications from unknown dates. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 21Mar2021 at 11:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 18:00, the patient experienced body aches, was restless all night, slept little and had low grade fever overnight which continued to 12Apr2021. On 12Apr2021, the patient had slept most of the day, had strong muscle aches. On 13Apr2021, the patient felt tired. The clinical outcome of the events body aches, restless all night, slept little, low grade fever, slept most of the day, strong muscle aches and tired were resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: Tired; Slept most of the day; Strong muscle aches; Body aches; Restless all night; Low grade fever; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 11Apr2021 at 11:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension. Concomitant medications included lisinopril 10mg (MANUFACTURER UNKNOWN), allium sativum extract (KYOLIC GARLIC), ascorbic acid, tocopheryl acetate, ubidecarenone, zinc oxide, cupric oxide, betacarotene, selenium, manganese sulfate (COQ10), cyanocobalamin (VITAMIN B12) and colecalciferol (VITAMIN D3), all taken for unknown indications from unknown dates. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 21Mar2021 at 11:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 18:00, the patient experienced body aches, was restless all night, slept little and had low grade fever overnight which continued to 12Apr2021. On 12Apr2021, the patient had slept most of the day, had strong muscle aches. On 13Apr2021, the patient felt tired. The clinical outcome of the events body aches, restless all night, slept little, low grade fever, slept most of the day, strong muscle aches and tired were resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Hordeolum
Clinical narrative: Developed a stye on right eye; This is a spontaneous report from a non-contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737), via an unspecified route of administration in the arm left on 15Apr2021(at the age of 41-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534), via an unspecified route of administration in the arm left on 25Mar2021(at the age of 41-year-old), as a single dose for COVID-19 immunisation. Since the vaccination, the patient had not been tested positive for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021, the patient developed a stye on right eye after receiving the second vaccine. The patient never had a stye before. The clinical outcome of the event stye on right eye was not recovered.   No follow-up attempts are needed. No further information is expected.